Frontiers in Pharmacology (Nov 2021)

Bias, Precision and Timeliness of Historical (Background) Rate Comparison Methods for Vaccine Safety Monitoring: An Empirical Multi-Database Analysis

  • Xintong Li,
  • Lana YH Lai,
  • Anna Ostropolets,
  • Faaizah Arshad,
  • Eng Hooi Tan,
  • Paula Casajust,
  • Thamir M. Alshammari,
  • Talita Duarte-Salles,
  • Evan P. Minty,
  • Carlos Areia,
  • Nicole Pratt,
  • Patrick B. Ryan,
  • Patrick B. Ryan,
  • George Hripcsak,
  • George Hripcsak,
  • Marc A. Suchard,
  • Marc A. Suchard,
  • Martijn J. Schuemie,
  • Martijn J. Schuemie,
  • Martijn J. Schuemie,
  • Daniel Prieto-Alhambra,
  • Daniel Prieto-Alhambra

DOI
https://doi.org/10.3389/fphar.2021.773875
Journal volume & issue
Vol. 12

Abstract

Read online

Using real-world data and past vaccination data, we conducted a large-scale experiment to quantify bias, precision and timeliness of different study designs to estimate historical background (expected) compared to post-vaccination (observed) rates of safety events for several vaccines. We used negative (not causally related) and positive control outcomes. The latter were synthetically generated true safety signals with incident rate ratios ranging from 1.5 to 4. Observed vs. expected analysis using within-database historical background rates is a sensitive but unspecific method for the identification of potential vaccine safety signals. Despite good discrimination, most analyses showed a tendency to overestimate risks, with 20%-100% type 1 error, but low (0% to 20%) type 2 error in the large databases included in our study. Efforts to improve the comparability of background and post-vaccine rates, including age-sex adjustment and anchoring background rates around a visit, reduced type 1 error and improved precision but residual systematic error persisted. Additionally, empirical calibration dramatically reduced type 1 to nominal but came at the cost of increasing type 2 error.

Keywords